Additionally, although the difference was not statistically significant, pancreatic adenocarcinoma (PAAD) patients with lower APC11 mRNA levels tended to have a lower overall survival probability (Figure S3f, Supporting Information). This evidence concerns the gene ANAPC11 and pancreatic adenocarcinoma.